Search filters

List of works by Willem P. Brouwer

A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B

scientific article published on 02 July 2018

Adding pegylated interferon to entecavir for hepatitis B e antigen-positive chronic hepatitis B: A multicenter randomized trial (ARES study).

scientific article

CD4+ CXCR5+ T cells in chronic HCV infection produce less IL-21, yet are efficient at supporting B cell responses

scientific article published on 2 October 2014

HBV Genotype-Specific Levels of Hepatitis B Surface Antigen Improve HBV Phenotype Definition

scientific article published on 07 January 2019

Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study

scientific article published on 18 September 2019

Hepatitis B core-related antigen levels are associated with response to entecavir and peginterferon add-on therapy in hepatitis B e antigen-positive chronic hepatitis B patients

scientific article

Hepatitis B core-related antigen monitoring during peginterferon alfa treatment for HBeAg-negative chronic hepatitis B

scientific article published on 04 August 2019

ITPA Polymorphisms Are Associated with Hematological Side Effects during Antiviral Therapy for Chronic HCV Infection

scientific article

Improved Survival beyond 28 Days up to 1 Year after CytoSorb Treatment for Refractory Septic Shock: A Propensity-Weighted Retrospective Survival Analysis

scientific article published on 22 December 2020

Interferon gamma receptor 2 gene variants are associated with liver fibrosis in the general population: the Rotterdam Study

scientific article published on 9 October 2014

Letter: rates and determinants of significant liver inflammation in chronic hepatitis B virus-infected patients with low ALT levels in the absence of significant fibrosis-authors' reply

scientific article published on 01 January 2021

Long-term follow-up of patients treated with entecavir and peginterferon add-on therapy for HBeAg-positive chronic hepatitis B infection: ARES long-term follow-up

scientific article published on 27 September 2018

Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B

scientific article published on 01 February 2019

Machine-learning based patient classification using Hepatitis B virus full-length genome quasispecies from Asian and European cohorts

scientific article published on 11 December 2019

Peginterferon add-on results in more HBsAg decline compared to monotherapy in HBeAg-positive chronic hepatitis B patients.

scientific article published on 25 September 2015

Polymorphisms of HLA-DP are associated with response to peginterferon in Caucasian patients with chronic hepatitis B.

scientific article published on 11 August 2014

Posttreatment Hepatitis B Surface Antigen Seroreversion: The Bane of Combination Therapy in Chronic Hepatitis B?

scientific article published on 25 March 2016

Prediction of long-term clinical outcome in a diverse chronic hepatitis B population: Role of the PAGE-B score.

scientific article published on 24 May 2017

Prevalence and risk factors for viral blipping in chronic hepatitis B patients treated with nucleos (t) ide analogues.

scientific article published on 9 August 2016

Real life adherence of chronic hepatitis B patients to entecavir treatment

scientific article published on 8 April 2015

Repeated Measurements of Hepatitis B Surface Antigen Identify Carriers of Inactive HBV During Long-term Follow-up

scientific article

Studies of IL28B genotype and response to peginterferon in chronic hepatitis B should be stratified by HBV genotype

scientific article published on 4 February 2013

Tenofovir alafenamide for hepatitis B: evolution or revolution?

scientific article

The impact of PNPLA3 (rs738409 C>G) polymorphisms on liver histology and long-term clinical outcome in chronic hepatitis B patients

scientific article published on 24 October 2014

The membrane-bound O-acyltransferase domain-containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B.

scientific article published on 20 January 2017

Toronto HCC Risk Index: A validated scoring system to predict 10-year risk of HCC in patients with cirrhosis

scientific article

Unique intrahepatic transcriptomics profiles discriminate the clinical phases of a chronic HBV infection.

scientific article

Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosis

scientific article published on 04 September 2020

Paulina is supported by:

About Paulina

Help